2025 Financial Times US Pharma and Biotech Summit Report

Guiding New Tailwinds into the Next Wave of Medical Innovation

To get our health back faster, stay healthy or even live longer and better lives are all fundamental wishes we now share due to the new realities that recent leaps in medicine have brought to bear.

The distance between our expectations and realities, however, keeps changing depending on where we live, our knowledge and educational background, socioeconomic status, as well as many headwinds or tailwinds blowing in our direction from our rapidly changing global healthcare ecosystem.

The 2025 Financial Times US Pharma and Biotech Summit held in May in New York gave voice to a multitude of industry leader perspectives on unprecedented regulation, new competition as well as a close glimpse at the sources of research and introspection that indicate a journey towards recovery.

This “InWeekend” issue highlights key insights from the 2025 FT Pharma US summit which focused on translating the latest healthcare developments into optimism and areas of further analysis.